Logo image of ICG

INTCHAINS GROUP LTD-ADR (ICG) Stock Fundamental Analysis

NASDAQ:ICG - Nasdaq - US45828E1047 - ADR - Currency: USD

4.09  -0.06 (-1.45%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ICG. ICG was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. ICG has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, ICG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ICG had negative earnings in the past year.
ICG had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ICG reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: ICG reported negative operating cash flow in multiple years.
ICG Yearly Net Income VS EBIT VS OCF VS FCFICG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of ICG (-2.74%) is worse than 62.96% of its industry peers.
With a Return On Equity value of -2.82%, ICG is not doing good in the industry: 60.19% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.74%
ROE -2.82%
ROIC N/A
ROA(3y)36.05%
ROA(5y)23.84%
ROE(3y)37.68%
ROE(5y)24.45%
ROIC(3y)N/A
ROIC(5y)N/A
ICG Yearly ROA, ROE, ROICICG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 20 -20 40 60

1.3 Margins

Looking at the Gross Margin, with a value of 11.10%, ICG is doing worse than 88.89% of the companies in the same industry.
In the last couple of years the Gross Margin of ICG has declined.
The Profit Margin and Operating Margin are not available for ICG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-42.25%
GM growth 5YN/A
ICG Yearly Profit, Operating, Gross MarginsICG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

ICG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ICG has been increased compared to 1 year ago.
ICG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ICG Yearly Shares OutstandingICG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M
ICG Yearly Total Debt VS Total AssetsICG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 39.33 indicates that ICG is not in any danger for bankruptcy at the moment.
ICG has a better Altman-Z score (39.33) than 94.44% of its industry peers.
ICG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 39.33
ROIC/WACCN/A
WACC12.76%
ICG Yearly LT Debt VS Equity VS FCFICG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

ICG has a Current Ratio of 28.32. This indicates that ICG is financially healthy and has no problem in meeting its short term obligations.
ICG has a better Current ratio (28.32) than 99.07% of its industry peers.
A Quick Ratio of 26.83 indicates that ICG has no problem at all paying its short term obligations.
ICG has a better Quick ratio (26.83) than 99.07% of its industry peers.
Industry RankSector Rank
Current Ratio 28.32
Quick Ratio 26.83
ICG Yearly Current Assets VS Current LiabilitesICG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

ICG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -107.43%.
Looking at the last year, ICG shows a very negative growth in Revenue. The Revenue has decreased by -82.64% in the last year.
Measured over the past years, ICG shows a quite strong growth in Revenue. The Revenue has been growing by 14.62% on average per year.
EPS 1Y (TTM)-107.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.49%
Revenue 1Y (TTM)-82.64%
Revenue growth 3Y14.62%
Revenue growth 5YN/A
Sales Q2Q%5.2%

3.2 Future

ICG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 216.73% yearly.
The Revenue is expected to grow by 163.77% on average over the next years. This is a very strong growth
EPS Next Y263.92%
EPS Next 2Y216.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year297.7%
Revenue Next 2Y163.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICG Yearly Revenue VS EstimatesICG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
ICG Yearly EPS VS EstimatesICG Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ICG. In the last year negative earnings were reported.
ICG is valuated quite expensively with a Price/Forward Earnings ratio of 293.45.
64.81% of the companies in the same industry are cheaper than ICG, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ICG to the average of the S&P500 Index (91.29), we can say ICG is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 293.45
ICG Price Earnings VS Forward Price EarningsICG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICG Per share dataICG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

ICG's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ICG's earnings are expected to grow with 216.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y216.73%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ICG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTCHAINS GROUP LTD-ADR

NASDAQ:ICG (1/29/2025, 8:00:02 PM)

4.09

-0.06 (-1.45%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-20 2024-11-20/amc
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner Change-100%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap245.45M
Analysts80
Price Target11.22 (174.33%)
Short Float %0.05%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 293.45
P/S 21.65
P/FCF N/A
P/OCF N/A
P/B 1.87
P/tB 1.88
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)0.01
Fwd EY0.34%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.19
BVpS2.19
TBVpS2.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.74%
ROE -2.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.1%
FCFM N/A
ROA(3y)36.05%
ROA(5y)23.84%
ROE(3y)37.68%
ROE(5y)24.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-42.25%
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1313.92%
Cap/Sales 61.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 28.32
Quick Ratio 26.83
Altman-Z 39.33
F-Score2
WACC12.76%
ROIC/WACCN/A
Cap/Depr(3y)612.05%
Cap/Depr(5y)392.23%
Cap/Sales(3y)20.78%
Cap/Sales(5y)12.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-107.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.49%
EPS Next Y263.92%
EPS Next 2Y216.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-82.64%
Revenue growth 3Y14.62%
Revenue growth 5YN/A
Sales Q2Q%5.2%
Revenue Next Year297.7%
Revenue Next 2Y163.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-120.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-117.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-101.44%
OCF growth 3YN/A
OCF growth 5YN/A